GlassScriptPhysician profile
Gazi Zibari
NPI 1497775282
$6,482.69
in general payments reported to CMS, 2019-2025
12 companies · $3,106 in 2025
The $3,106 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.45 · 2020: $237 · 2022: $16.22 · 2023: $15.56 · 2024: $3,016 · 2025: $3,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,576 · Education: $1,500 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,576.23 |
| Education | $1,500.00 |
| Food and Beverage | $1,061.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,171.61 | 2024-2025 | |
| Histosonics, INC. | $2,429.41 | 2024-2025 | |
| Eurofins Viracor, LLC | $199.00 | 2024 | |
| Olympus America INC. | $165.02 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $150.00 | 2024 | |
| Heron Therapeutics, INC. | $125.00 | 2025 | Zynrelef |
| Shionogi INC | $125.00 | 2020 | |
| Ethicon US, LLC | $45.16 | 2020-2025 | Echelon Flex |
| Cook Medical LLC | $25.32 | 2019 | |
| Hologic Sales and Service, LLC | $16.22 | 2022 | |
| Lemaitre Vascular, INC. | $15.56 | 2023 | Artegraft Vascular Graft |
| Medtronic, INC. | $15.39 | 2025 | Signia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gazi Zibari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.